Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.
Also called NCT02625948
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 240 participants
- Sponsor
- Registry
-
NCT02625948
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02625948. Randomized; quadruple masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2018-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign
- Acronym
- TRAIGE
- Condition
- Intracerebral Hemorrhage
- Condition
- Stroke
- Intervention (Drug)
- Tranexamic Acid
- Lead sponsor
- Ministry of Science and Technology of the People´s Republic of China
- Collaborator
- Beijing Municipal Science & Technology Commission
Record details
- Record id
cardio:ct-nct02625948- Content hash
036e3a173fe57759b6b222d9e5863b5e65188eec2f37c7c2e308029a97c39068